An innovator in biopharma market access, Tate currently leads AccessSync in providing integrated solutions for life sciences manufacturers. This includes developing data-driven strategies and tactics implemented through proprietary technologies to deliver maximum impact.
Tate’s involvement in biopharma started with managing strategic customer marketing initiatives at Johnson & Johnson. He then founded Profero Group in 2004 in response to an emerging need for partners capable of both developing and implementing comprehensive access marketing strategies and tactics. He led Profero for 14 years, building a multi-disciplinary team and expanding capabilities to service clients representing over 50 brands across 30 therapeutic areas. He is also a current member of the Elandas Inc. Advisory Board, where he leverages his unique industry experience to help direct strategic development of next generation market access technology solutions. Prior to launching his biopharma career, Tate spent time evaluating and implementing strategic alliances with American Express and Rosenbluth International, and managing key accounts for Tokyo-based Riken Technos Corporation.
Tate holds a Bachelor’s in Economics from the University of Delaware, a Master’s in East Asian Studies from the University of Pennsylvania, and an MBA from The Wharton School in Finance and Entrepreneurial Management. He is also an Advisor to the Horn Program in Entrepreneurship at the University of Delaware.